Valens Groworks Corp (OTCMKTS:VGWCF) has signed a 2-year supply accord with BRNT Ltd. As per the terms of the deal, Valens would supply 2.2 million vape pens under the brand – BRNT. The company would benefit from revenues of more than $50 million in the first two years of operation. Valens can extend the agreement for another two years extendable every year.
First shipment to begin in Q1 2020
Valens would begin the supply of good quality cannabis extracts, vape pens and filling services across the nation. BRNT is experiencing rapid growth across the nation. It has a presence in the ancillary products segment by offering high quality and premium cannabis accessories through more than 170 stores in Canada. The company is also undertaking global expansion with the help of cannabis extract vaporizers.
Chief Executive Officer of Valens, Tyler Robson, commenting on the deal said the company is excited to bring high quality, differentiated, and concentrate vape products in Canada by collaborating with BRNT. According to Tyler, BRNT registered a remarkable growth in sales. Valence would combine the product development and processing capabilities with the product knowledge and retail experience of BRNT to offer products with a strong appeal to the consumers.
Chief Executive Officer of BRNT, Simon Grigenas, said Valens demonstrated its capability to deliver high-quality cannabis extraction on an International scale. He said the accord with Valens is a natural fit for the company’s endeavor to launch Made By vaporizers to the life.
Valence posts robust growth
Valence has registered a growth of 87.1% since Q2 2019 and posted revenues of $16.5 million in Q3 2019. Tyler said the robust growth over the past two quarters is on the backdrop of scaling up extraction operations and rolling out a business plan. He further said excellent growth in Q3 demonstrates its ability to offer good quality products and cutting edge technical capabilities. As the company focuses on increased volumes and efficiencies, the future quarters expect to offer improved margins.
Valence processed 26,625 kgs of hemp biomass and dried cannabis in Q3 2019. It is an increase of 212% than in the previous quarter.
Valence signed an accord with Shoppers Drug Mart to supply cannabis oil products.
Zoned Properties Inc (OTCMKTS:ZDPY) Reports $1.22 Million Revenues In 2020
Zoned Properties Inc (OTCMKTS:ZDPY) posted revenues of $1.22 million in 2020. The company’s operating expenses declined marginally to $1.18 million in 2020. Its cash balance improved to $699,000 at the end of the year.
The company reported revenues of $309,000 in Q4 2020. Its operating expenses dropped marginally in the quarter to $268,000.
Zoned Properties expects to receive $8 million by leveraging its property portfolio in Arizona. The company will use these proceeds for expanding infrastructure.
Zoned Properties is expanding its projects in Chino Valley, Arizona, with an investment of $8 million as of today. It expects to be functional in Q2 2021 and generate significant revenues.
Invests $100,000 in The Open Dør
Zoned properties a sum of $100,000 in Open Dør, the national cannabis franchise retailer. The company added $200,000 in this franchise towards the end of 2020. It will get a certain percentage of franchise fee as well as renewal fee for these investments. The company may convert this fee into a stake of 33% in Open Dør.
CEO of Zoned Properties, Bryan McLaren, said it plays an important role in positioning the company as a leading player in developing real estate. It mainly focuses on the regulated cannabis industry.
The company chose a value-driven approach to benefit from the regulated landscape. Bryan further said its growth strategy positions Zoned Properties to take advantage of investment opportunities.
Bryan has the vision to offer sustainability and real estate services to the regulated cannabis industry. As a sustainability consultant, Bryan engaged in operational implementation and strategic development of Higher Educational customers in his previous stints.
Healthier Choices to offer rights to investors
Healthier Choices Management Corp (OTCMKTS:HCMC) applies with the SEC (Securities and Exchange Commission) to offer rights to investors. CEO of Healthier Choices, Jeffrey Holman, thanked investors for their valued support so far besides its employees for working relentlessly even during the pandemic.
Healthier Choices will not pursue a reverse stock split at the moment. The company needs additional funding to support growth and protect its IP.
It will generate funds through rights issues mainly to its valued investors. Under the rights offering, the shareholders can acquire common stock at a discounted price.
Canntab Therapeutics Limited (OTCMKTS:CTABF) has announced that it has received an Export License from Health Canada.
Canntab receives order from Cann Global
According to the company’s announcement of March 9, 2021, it will now fulfill a purchase order from Cann Global limited. Cann Global’s initial purchase order of $406,200 includes 6 SKUs that comprise 25mg THC, 5mg THC, and 2.5mg THC. It also includes combined caplets with 12.5mg VBD/2.5mg THC and 25mg CBD/5mg THC. The ordered products will be distributed across Australia to medical distributors such as pharmacies, hospitals, and doctors.
Canntab CEO Larry Latowsky said that they are delighted to receive the export license from Health Canada, which will enable the company to meet orders from its Australian partners immediately. He said that this is the first export order for the company, and they expect many more such orders from other international partners besides Canntab. Similarly, the order allows the company to participate in a medical cannabis study. Already the company has engaged Cann Global to commence necessary preparations and preparations to carry clinical blood tests to measure the efficacy of Cannatab’s immediate and future products expected to conclude in the company’s Q3.
Auxly shares uplifted from TSXV to TSX
Auxly Cannabis Group Inc. (OTCMKTS:CBWTF) has announced that the Toronto Stock Exchange has given it conditional approval to graduate to GTSX from the TSX Venture Exchange. Hugo Laves, the company’s CEO, said that the conditional approval to graduate to TSX is a massive milestone. He said that after the successful launch of Cannabis 2.0 in 2020 and Auxly’s strategic expansion to Cannabis 1.0 this year, they are optimistic that the upgrade is a logical step in Auxly’s corporate growth. Hugo said that the uplisting of the company’s profile in the investment community enables Auxly to continue building shareholder value.
However, the approval is subject to Auxly meeting certain customary and standard conditions needed by the TSX. Auxly plans to meet the requirements immediately and will issue a statement once the trading date is confirmed.
Vireo Health International Inc. (OTCMKTS:VREOF) Completes Expansion Of New Mexico Cultivation Facility
Vireo Health International Inc. (OTCMKTS:VREOF) has announced the completion of the planned expansion of its New Mexico cultivation and processing facility. The company also announced the recent completion of two retail dispensaries Las Cruces and Albuquerque, which are ready to launch pending regulatory approval. After the approval of the dispensaries, the company will now have four operating dispensaries in New Mexico.
Vireo expanding in New Mexico with two more dispensaries
The company’s affiliate, Red Barn Growers, completed a new cultivation facility in Gallup, New Mexico. The site includes six polycarbonate hoop houses for cultivation year-round and an extra 12,600 sq. ft. cultivation space. Already construction has been finalized, and planting will commence immediately the New Mexico Department of Health approves. The additional facilities will support the growing demand the company is witnessing in the Gallup and Santa Fe dispensaries.
Vireo Health CEO Kyle Kingsley said that the company’s strategic investment in retail and cultivation operations in New Mexico will create more opportunities to boost market profitability that is riding on favorable regulatory changes tailwinds. He said that the expansion projects will create new jobs in the company’s operating communities and meet growing cannabis products demand in New Mexico following the adult-use legislation passage.
Vireo enters Mutual Release with ex-executive chairman Bruce Linton
The company recently announced the signing of a mutual release with Bruce Linton, a renowned cannabinoid business and policy authority, and its ex-executive chairman, regarding outstanding matters between them. Linton joined the company in November 2019, and on June 8, 2020, the company moved to terminate his employment as executive chairman on a without-cause-basis. Linton had received warrants to acquire 15 million shares of the company and 10 million Warrants at an exercise price of $1.02 per share in connection to the employment agreement.
According to the Mutual Release, the company has issued around 8 million shares to Linton, with 7.11 million shares issued pursuant to the exercise of First Tranche Warrants and the 0.889 million shares issued under private placement exemption.